Mode
Text Size
Log in / Sign up

Ultramarathon running alters glucose dynamics in three distinct phases

Ultramarathon running alters glucose dynamics in three distinct phases
Photo by Fitsum Admasu / Unsplash
Key Takeaway
Consider that ultramarathon running alters glucose dynamics in three phases, but direct evidence is limited.

This mini-review examines glucose dynamics in ultramarathon runners, synthesizing available evidence on blood glucose changes during prolonged running. The authors describe a three-phase pattern: transient elevations in the first phase, a gradual decline in the second phase, and increased variability leading to transient elevations in the third phase. Notably, late-stage blood glucose increases cannot be fully explained by conventional determinants such as carbohydrate intake or exercise intensity.

The review highlights that direct evidence on glucose dynamics in ultramarathon runners remains limited, and the findings are based on a small body of research. The authors do not report sample sizes, comparators, or quantitative effect sizes, and no safety data are provided.

Despite these limitations, the authors suggest that continuous glucose monitors (CGMs) may provide a useful tool for identifying overall trends in glucose dynamics and supporting individualized nutritional strategies during ultramarathon running. Clinicians should interpret these findings cautiously given the limited evidence base.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Ultramarathon running is characterized by extreme duration and substantial physiological stress, making individualized nutritional strategies essential for performance and completion. This mini-review examines glucose dynamics during ultramarathon running using continuous glucose monitors (CGMs) and proposes a conceptual multi-phase framework. Glucose dynamics during ultramarathon running can be conceptualized into three phases. The first phase is characterized by transient elevations in blood glucose. In the second phase, a gradual decline in blood glucose is observed. The third phase is characterized by an increase in glucose variability, leading to transient elevations in blood glucose. Importantly, late-stage increases in blood glucose levels cannot be fully explained by conventional determinants such as carbohydrate intake or exercise intensity. Potential mechanisms underlying these observations include changes in substrate utilization and cumulative inflammatory stress. These changes may impair glucose uptake in skeletal muscle and contribute to a mismatch between glucose availability and utilization. Although direct evidence remains limited, CGMs may provide a useful tool for identifying overall trends in glucose dynamics and supporting individualized nutritional strategies during ultramarathon running.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.